Reporting Modifiers in the Compound Drug Segment

70.1.1 - Reporting Modifiers in the Compound Drug Segment (Rev. 1, 10-01-03) Certain informational modifiers are required on compound ingredients. The NCPDP format does not currently support reporting modifiers in the compound segment. Therefore, the narrative portion in the prior authorization segment must be used to report these modifiers. The following must be entered in positions 001-003 of the narrative (Example, MMN or MNF). Starting at position 355, indicate the two-byte ingredient number followed by the two-position modifier: MMN - Indicates that the Supporting documentation that follows is Medicare modifier information and CMN information or DIF information MNA - Indicates that the Supporting documentation that follows is Medicare modifier information, CMN information or DIF information and narrative information MFA - Indicates that the Supporting documentation that follows is Medicare modifier information, CMN information or DIF information and Facility Name and Address MNF - Indicates that the Supporting documentation that follows is Medicare modifier information, CMN information or DIF information, narrative information and Facility Name and Address MAC - Indicates that the Supporting documentation that follows is Medicare modifier information and Facility Name and Address MAN - Indicates that the Supporting documentation that follows is Medicare modifier information, narrative information and Facility Name and Address MAR - Indicates that the Supporting documentation that follows is Medicare modifier information and narrative information